Goodwill and Intangible Assets, Net (Tables)

12 Months Ended

Dec. 31, 2017

Goodwill And Intangible Assets Disclosure [Abstract]

Schedule of Changes in Carrying Amount of Goodwill for each Reporting Unit

The changes in the carrying amount of goodwill for each reporting unit with goodwill for the periods indicated are as follows (in thousands):

	QuaDPharma		Polymed			Oncology Innovation Platform			Total
Balance as of December 31, 2015	$	4,586	$	22,031		$	11,379		$	37,996
Effect of currency translation adjustment		—		(439	)		(5	)		(444	)
Balance as of December 31, 2016		4,586		21,592			11,374			37,552
Effect of currency translation adjustment		—		332			(89	)		243
Balance as of December 31, 2017	$	4,586	$	21,924		$	11,285		$	37,795

Summary of Identifiable Intangible Asset, Net

The Company’s identifiable intangible assets, net, consist of the following (in thousands):

	December 31, 2017
	Cost/Fair Value			Accumulated Amortization		Impairments		Net
Amortizable intangible assets
Licenses	$	4,650		$	1,173	$	—	$	3,477
Polymed customer list		1,593			675		—		918
Polymed technology		3,712			762		—		2,950
Product rights		530			132		—		398
Indefinite-lived intangible assets:
CDE in-process research and development (IPR&D)		1,106			—		80		1,026
Effect of currency translation adjustment		(197	)		—		—		(197	)
Total intangibles, net	$	11,394		$	2,742	$	80	$	8,572

	December 31, 2016
	Cost/Fair Value			Accumulated Amortization		Impairments		Net
Amortizable intangible assets
Licenses	$	3,100		$	315	$	—	$	2,785
QuaDPharma customer list		204			58		146		—
Polymed customer list		1,593			414		—		1,179
Polymed technology		3,712			437		—		3,275
Indefinite-lived intangible assets:
CDE in-process research and development (IPR&D)		1,884			—		248		1,636
Effect of currency translation adjustment		(411	)		—		—		(411	)
Total intangibles, net	$	10,082		$	1,224	$	394	$	8,464

Schedule of Expected Amortization Expense of Finite Lived Intangible Expense

The Company expects amortization expense related to its finite-lived intangible assets for the next 5 years and thereafter to be as follows as of December 31, 2017 (in thousands):

Year ending December 31:	Estimated Amortization Expense
2018	$	1,588
2019		1,588
2020		1,588
2021		1,127
2022		392
Thereafter		1,460
	$	7,743